摘要
目的探讨HOX转录反义RNA表达对胸腔镜食管癌切除术后风险的预测价值。方法收集该院接受胸腔镜食管癌切除术患者92例,采用RT-PCR检测术后组织中HOX转录反义RNA表达情况,分析HOX转录反义RNA表达与食管癌术后复发、生存状况之间的关系。结果 RT-PCR显示,癌组织HOTAIR相对表达量为(0.673±0.076),而癌旁组织为(0.387±0.058),两组比较差异有统计学意义(P<0.05)。HOTAIR对术后复发诊断的曲线下面积为0.727(95%CI:0.684,0.884),对术后生存诊断的曲线下面积为0.769(95%CI:0.692,0.901)。术后3年内,HOTAIR相对表达量≤0.5组复发率低于HOTAIR相对表达量>0.5组(P<0.05)。Cox模型分析显示,分化程度、临床分期、肿瘤直径、淋巴结转移及HOTAIR为预后的危险因素,而术后辅助放、化疗为预后的保护因素。结论 HOTAIR为胸腔镜食管癌切除术后复发、生存状况的影响因素,通过对HOTAIR的检测可以为临床选择合理的治疗方案提供参考依据。
Objective To investigate the prognostic value of HOX transcribed antisense RNA expression in patients with thoracoscopic esophagostomy. Methods Totally 92 patients undergoing thoracoscopic esophageal cancer resection were included in this study. Cancer tissue as well as para-cancer normal tissue was collected. RT-PCR was utilized to detect the expression of HOX transcribed antisense RNA. Correlation between HOX transcribed antisense RNA expression and postoperative recurrence as well as survival was analyzed. Results RT-PCR showed that the relative expression of HOTAIR in cancer tissue increased signifcantly when compared with that in normal tissue [（0.673 ± 0.076） vs （0.387 ± 0.058）, P 〈 0.05]. The area under the curve of HOTAIR for postoperative recurrence was 0.727 （95% CI： 0.684, 0.884）, and that for postoperative survival was 0.769 （95% CI： 0.692, 0.901）. At time point of the 3rd year post operation, recurrence rate in group with HOTAIR less than 0.5 was dramatically lower than that of group with HOTAIR 〉 0.5 group （P 〈 0.05）. Cox model analysis indicated that the degree of differentiation, clinical stage, tumor diameter, lymph node metastasis and HOTAIR were risk factors while postoperative adjuvant radiotherapy and chemotherapy was beneficial for the prognosis of patients. Conclusion HOTAIR is the risk factor for the prognosis of patients experiencing thoracoscopic esophagostomy, which can serve as a prognostic biomarker of esophageal cancer.
出处
《中国现代医学杂志》
CAS
2018年第3期28-34,共7页
China Journal of Modern Medicine
关键词
食管癌
胸腔镜手术
HOX转录反义RNA
生存率
esophageal carcinoma
thoracoscopic surgery
hox transcriptional antisense rna
survival rate
